Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

iSpecimen (ISPC) Other financing activities (2024)

iSpecimen has reported Other financing activities over the past 1 years, most recently at -$124519.0 for Q4 2024.

For Q4 2024, Other financing activities changed N/A year-over-year to -$124519.0; the TTM value through Dec 2024 reached $15501.0, changed N/A, while the annual FY2024 figure was $15501.0, N/A changed from the prior year.
Other financing activities for Q4 2024 was -$124519.0 at iSpecimen, down from -$115268.0 in the prior quarter.
Over five years, Other financing activities peaked at $204845.0 in Q1 2024 and troughed at -$124519.0 in Q4 2024.